Stockscreener 앱 받기
0.32
13.49%
-0.0499
시간 외 거래:
.31
-0.01
-3.13%
전일 마감가:
$0.3699
열려 있는:
$0.3405
하루 거래량:
4.92M
Relative Volume:
0.26
시가총액:
$13.37M
수익:
$20.27M
순이익/손실:
$-63.80M
주가수익비율:
-0.2105
EPS:
-1.52
순현금흐름:
$-68.35M
1주 성능:
+40.35%
1개월 성능:
+3.90%
6개월 성능:
-20.02%
1년 성능:
-68.00%
1일 변동 폭
$0.316
$0.37
1주일 범위
$0.2106
$0.556
52주 변동 폭
$0.1417
$1.27
Carisma Therapeutics Inc Stock (CARM) Company Profile
명칭
Carisma Therapeutics Inc
전화
(267) 491-6422
주소
3675 MARKET STREET, PHILADELPHIA
CARM을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CARM
Carisma Therapeutics Inc
|
0.32 | 18.39M | 20.27M | -63.80M | -68.35M | -1.52 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Carisma Therapeutics Inc Stock (CARM) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-12-12 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2024-12-10 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2024-04-11 | 개시 | BTIG Research | Buy |
| 2023-10-03 | 개시 | CapitalOne | Overweight |
| 2023-07-06 | 개시 | Evercore ISI | Outperform |
| 2023-05-31 | 업그레이드 | Jefferies | Hold → Buy |
| 2023-05-24 | 개시 | H.C. Wainwright | Buy |
| 2023-04-14 | 개시 | Robert W. Baird | Outperform |
모두보기
Carisma Therapeutics Inc 주식(CARM)의 최신 뉴스
What is Carisma Therapeutics Inc. s 5 year growth outlookOil Prices & Real-Time Volume Surge Alerts - khodrobank.com
How to integrate Carisma Therapeutics Inc. into portfolio analysis tools2025 Historical Comparison & Real-Time Stock Movement Alerts - Newser
Is Carisma Therapeutics Inc. building a consolidation baseJuly 2025 Price Swings & Reliable Price Breakout Signals - Newser
Why CARISMA Therapeutics (CARM.O) Plunged 11.8%—No News, But Technicals and Order Flow Tell the Story - AInvest
Will Carisma Therapeutics Inc. rebound enough to break evenCPI Data & Reliable Breakout Forecasts - Newser
Detecting price anomalies in Carisma Therapeutics Inc. with AIJuly 2025 Action & AI Enhanced Trading Signals - Newser
Will Carisma Therapeutics Inc. price bounce be sustainable2025 Winners & Losers & Fast Entry High Yield Tips - Newser
Will Carisma Therapeutics Inc. see short term momentumDip Buying & Intraday High Probability Setup Alerts - Newser
Carisma Therapeutics Inc. stock momentum explainedQuarterly Earnings Report & Risk Managed Investment Entry Signals - Newser
CARISMA Therapeutics Plunges 10.68% as HealthCap VII Sells Shares - AInvest
What Fibonacci levels say about Carisma Therapeutics Inc. reboundPortfolio Update Summary & Low Risk High Reward Trade Ideas - Newser
Applying Wyckoff theory to Carisma Therapeutics Inc. stockTrade Volume Report & Daily Technical Stock Forecast Reports - Newser
Relative strength of Carisma Therapeutics Inc. in sector analysisQuarterly Performance Summary & Daily Market Momentum Tracking - Newser
Carisma Therapeutics Inc. stock prediction for this week2025 Performance Recap & Weekly High Momentum Picks - Newser
Carisma Therapeutics stock soars after merger agreement with Ocugen - Investing.com
Carisma Therapeutics stock soars after merger agreement with Ocugen By Investing.com - Investing.com UK
Carisma Therapeutics (CARM) Surges 118% on Merger Spark – What’s Next for This Biotech Cinderella? - AInvest
Nasdaq Down 1%; Signet Jewelers Earnings Top Views - Benzinga
Why Is Carisma Therapeutics Stock (CARM) Up 165% Today? - TipRanks
Will Carisma Therapeutics Inc. continue its uptrendMarket Growth Summary & Consistent Profit Focused Trading Strategies - Newser
Forecasting Carisma Therapeutics Inc. price range with options dataStop Loss & Daily Stock Trend Reports - Newser
Why Carisma Therapeutics Shares Are Trading Higher By 133%; Here Are 20 Stocks Moving Premarket - inkl
CARISMA Therapeutics Stock Soars 150.23% on Investor Optimism - AInvest
Using flow based indicators on Carisma Therapeutics Inc.Weekly Trend Report & Daily Technical Forecast Reports - Newser
Carisma Therapeutics Inc. stock retracement – recovery analysis2025 Winners & Losers & Fast Exit and Entry Strategy Plans - Newser
Analyzing net buyer seller activity in Carisma Therapeutics Inc.Trade Volume Summary & Weekly Stock Breakout Alerts - Newser
Does Carisma Therapeutics Inc. qualify in momentum factor screeningEarnings Recap Summary & Precise Trade Entry Recommendations - Newser
Will Carisma Therapeutics Inc. stock recover after recent dropTrade Analysis Report & Low Drawdown Trading Strategies - Newser
Applying sector rotation models to Carisma Therapeutics Inc.July 2025 Rallies & Daily Chart Pattern Signals - Newser
Visual analytics tools that track Carisma Therapeutics Inc. performanceRisk Management & Advanced Technical Signal Analysis - Newser
Tick level data insight on Carisma Therapeutics Inc. volatilityMarket Risk Report & Fast Gain Stock Trading Tips - Newser
What the charts say about Carisma Therapeutics Inc. todayTrade Volume Report & Low Risk High Reward Ideas - Newser
Combining price and volume data for Carisma Therapeutics Inc.July 2025 Patterns & Capital Efficiency Focused Ideas - Newser
Halozyme Therapeutics Inc. stock volume spike explainedTrade Risk Assessment & Fast Gain Stock Tips - Newser
What to expect from Carisma Therapeutics Inc. in the next 30 daysJuly 2025 Decliners & Free Daily Entry Point Trade Alerts - Newser
Building trade automation scripts for Carisma Therapeutics Inc.2025 Historical Comparison & Reliable Volume Spike Alerts - Newser
Carisma Therapeutics Inc (CARM) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.75%
1.11%
자본화:
|
볼륨(24시간):